Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 73%
Hold 9%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT is expected to see strong growth in its revenue per available day (RevPAR) in 2026 and 2027 due to the stable operating performance of its Integrated Senior Health Campus/Trilogy and SHOP segments. This growth is also supported by the company's investment accretion and moderating interest expense. Despite regulatory risks and concerns about its largest tenant/operator, Trilogy, AHR's strong market position and competitive advantage in the healthcare real estate space make it a favorable investment with an attractive earnings growth outlook.

Bears say

American Healthcare REIT is facing significant risks from several areas, including tenant risk, development and redevelopment risk, and interest rate risk. Furthermore, the company is highly dependent on its Trilogy segment, which contributes to the majority of its revenue. The unpredictable nature of the healthcare industry, labor availability risks, and potential changes in regulations could also adversely affect the company's operations. Additionally, there are concerns about the company's ability to sustain its dividend and manage its cost of capital, and investors should carefully consider these risks before investing in the company's stock.

AHR has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 73% recommend Buy, 9% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 11 analysts, AHR has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $54.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $54.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.